Botulinum toxin A (Shanghai Ruoyi Biotech)

A型肉毒毒素（苏州若弋生物）

Report date: 2026/05/14 20:00:28

Base Information

Drug NameBotulinum toxin A (Shanghai Ruoyi Biotech)
Drug Alias NameBotulinum toxin type A (Lanzhou Institute of Biological Products)注射用重组A型肉毒毒素（Sf9细胞，150 kD天然氨基酸序列）
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsNasolabial fold wrinklesGlabellar linesUpper limb spasticity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Ruoyi Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Ruoyi Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsGlabellar linesUpper limb spasticityMasseter Muscle Prominence
Inactive IndicationsNasolabial fold wrinkles

Other Information

ATC CodeN/A
Related LinksN/A